Clinical Trials Logo

Stage 2A Neuroblastoma clinical trials

View clinical trials related to Stage 2A Neuroblastoma.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03057626 Active, not recruiting - Clinical trials for Recurrent Neuroblastoma

Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

Start date: June 5, 2017
Phase:
Study type: Observational

This research trial studies late effects after treatment in patients with previously diagnosed high-risk neuroblastoma. Studying late effects after treatment may help to decide which treatments for high-risk neuroblastoma are better tolerated with less side effects over time.

NCT ID: NCT01798004 Active, not recruiting - Clinical trials for Ganglioneuroblastoma

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Start date: April 8, 2013
Phase: Phase 1
Study type: Interventional

This pilot clinical trial studies busulfan, melphalan, and stem cell transplant after chemotherapy in treating patients with newly diagnosed neuroblastoma that is likely to come back or spread. Giving chemotherapy to the entire body before a stem cell transplant stops the growth of tumor cells by stopping them from dividing or killing them. After treatment, stem cells are collected from the patient's blood and stored. More chemotherapy or radiation therapy is given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy.